Matthieu Allez

24PUBLICATIONS
81CO-AUTHORS
Major global burdens of diseaseCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 19, 2025
Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-Analysis.

Mohammad Shehab, Omar Alrashed, Fatema Alrashed

|Jul 15, 2025
Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer.

Janine Kövilein, Adam Sorbie, Sevana Khaloian

|Jun 13, 2025
A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn's disease: the TEOREM trial.

Franck Carbonnel, Nicolas Barnich, Patricia Lepage

|Mar 05, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.

Nicolas Richard, Aurélien Amiot, Philippe Seksik

|Jan 25, 2025
The Impact of Postoperative Prophylactic Medication on Long-Term Surgical, Severe Endoscopic and Endoscopic or Radiologic Recurrence Following Primary Ileocecal Resection in Patients With Crohn's Disease.

Sebastiaan Ten Bokkel Huinink, Michiel T J Bak, Evelien M J Beelen

|Nov 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial.

Aurelien Amiot, Philippe Seksik, Antoine Meyer

Pageof 4

Frequent Collaborators

6 joint publications

David Laharie

6 joint publications

Anthony Buisson

5 joint publications

Guillaume Bouguen

5 joint publications

Aurelien Amiot